Literature DB >> 6338444

The radiology of osteomyelitis.

A Bonakdar-pour, V D Gaines.   

Abstract

In the early stages of acute osteomyelitis, bone scanning is especially helpful. It is important to correlate the bone scan with clinical findings because the scan is nonspecific. Radiograms reveal the extent of disease, but may lag behind clinical findings; however, plain film studies may reveal sequestra not seen by other means. Gallium scanning may be of value in osteomyelitis, as may be computerized tomography.

Entities:  

Mesh:

Year:  1983        PMID: 6338444

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  6 in total

Review 1.  Radionuclide bone scanning.

Authors:  H Carty
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

Review 2.  Management of destructive Candida albicans spondylodiscitis of the cervical spine: a systematic analysis of literature illustrated by an unusual case.

Authors:  Josef Stolberg-Stolberg; Dagmar Horn; Steffen Roßlenbroich; Oliver Riesenbeck; Stefanie Kampmeier; Michael Mohr; Michael J Raschke; René Hartensuer
Journal:  Eur Spine J       Date:  2016-11-05       Impact factor: 3.134

Review 3.  Multimodality imaging of osteomyelitis.

Authors:  A H Elgazzar; H M Abdel-Dayem; J D Clark; H R Maxon
Journal:  Eur J Nucl Med       Date:  1995-09

4.  Fever of unknown origin as the first presentation of candida vertebral osteomyelitis: A case report.

Authors:  Athena Farahzadi; Habibollah Mahmoodzadeh
Journal:  Clin Case Rep       Date:  2022-03-23

5.  Imaging of infection: a correlative and algorithmic approach.

Authors:  A H Elgazzar
Journal:  J Family Community Med       Date:  1997-07

Review 6.  MRI nomenclature for musculoskeletal infection.

Authors:  Erin F Alaia; Avneesh Chhabra; Claus S Simpfendorfer; Micah Cohen; Douglas N Mintz; Josephina A Vossen; Adam C Zoga; Jan Fritz; Charles E Spritzer; David G Armstrong; William B Morrison
Journal:  Skeletal Radiol       Date:  2021-06-18       Impact factor: 2.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.